Lilly/Novo Get Priority Reviews For Lowering Drug Prices

 
• By Jessica Merrill
  
Lilly and Novo Nordisk gained priority review vouches for lower GLP-1 prices (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Business